Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
来源期刊:CancersDOI:10.3390/cancers11091334
Integrins, CAFs and Mechanical Forces in the Progression of Cancer
来源期刊:CancersDOI:10.3390/cancers11050721
Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades
来源期刊:CancersDOI:10.3390/cancers11060813
The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair
来源期刊:CancersDOI:10.3390/cancers11070946
Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle
来源期刊:CancersDOI:10.3390/cancers11091264
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
来源期刊:CancersDOI:10.3390/cancers11070995
MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer
来源期刊:CancersDOI:10.3390/cancers11030378
The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis
来源期刊:CancersDOI:10.3390/cancers11060832
Pretreatment Cancer-Related Cognitive Impairment—Mechanisms and Outlook
来源期刊:CancersDOI:10.3390/cancers11050687
Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
来源期刊:CancersDOI:10.3390/cancers11070954
Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
来源期刊:CancersDOI:10.3390/cancers11060805
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project
来源期刊:CancersDOI:10.3390/cancers11081061
Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma
来源期刊:CancersDOI:10.3390/cancers11070986
Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
来源期刊:CancersDOI:10.3390/cancers11091269
Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications
来源期刊:CancersDOI:10.3390/cancers11111802
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
来源期刊:CancersDOI:10.3390/cancers11070981
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma
来源期刊:CancersDOI:10.3390/cancers11050694
Wnt Signaling Pathways in Keratinocyte Carcinomas
来源期刊:CancersDOI:10.3390/cancers11091216
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome
来源期刊:CancersDOI:10.3390/cancers11091219
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials
来源期刊:CancersDOI:10.3390/cancers11111661
The Chalcone Lonchocarpin Inhibits Wnt/β-Catenin Signaling and Suppresses Colorectal Cancer Proliferation
来源期刊:CancersDOI:10.3390/cancers11121968
Type 1 Sodium Calcium Exchanger Forms a Complex with Carbonic Anhydrase IX and Via Reverse Mode Activity Contributes to pH Control in Hypoxic Tumors
来源期刊:CancersDOI:10.3390/cancers11081139
Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029
来源期刊:CancersDOI:10.3390/cancers11020179
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
来源期刊:CancersDOI:10.3390/cancers11121940
HOX Genes in High Grade Ovarian Cancer
来源期刊:CancersDOI:10.3390/cancers11081107
Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis
来源期刊:CancersDOI:10.3390/cancers11070970
Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
来源期刊:CancersDOI:10.3390/cancers11050648
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells
来源期刊:CancersDOI:10.3390/cancers11081129
3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms
来源期刊:CancersDOI:10.3390/cancers11020130
Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers
来源期刊:CancersDOI:10.3390/cancers11010103
Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
来源期刊:CancersDOI:10.3390/cancers11050653
Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
来源期刊:CancersDOI:10.3390/cancers11060802
The History of Armand Trousseau and Cancer-Associated Thrombosis
来源期刊:CancersDOI:10.3390/cancers11020158
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer
来源期刊:CancersDOI:10.3390/cancers12010104
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas
来源期刊:CancersDOI:10.3390/cancers11091238
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
来源期刊:CancersDOI:10.3390/cancers11081137
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer
来源期刊:CancersDOI:10.3390/cancers11091372
Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases
来源期刊:CancersDOI:10.3390/cancers11060811
In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
来源期刊:CancersDOI:10.3390/cancers11101446
CNOT2 Is Critically Involved in Atorvastatin Induced Apoptotic and Autophagic Cell Death in Non-Small Cell Lung Cancers
来源期刊:CancersDOI:10.3390/cancers11101470
FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma
来源期刊:CancersDOI:10.3390/cancers11101427
Long-Term Visual Outcomes for Small Uveal Melanoma Staged T1 Treated by Proton Beam Radiotherapy
来源期刊:CancersDOI:10.3390/cancers11081047
Discovering Rare Genes Contributing to Cancer Stemness and Invasive Potential by GBM Single-Cell Transcriptional Analysis
来源期刊:CancersDOI:10.3390/cancers11122025
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients
来源期刊:CancersDOI:10.3390/cancers11040464
YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma
来源期刊:CancersDOI:10.3390/cancers11050661
Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma
来源期刊:CancersDOI:10.3390/cancers11111672
Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical Outcomes
来源期刊:CancersDOI:10.3390/cancers12010046
The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300
来源期刊:CancersDOI:10.3390/cancers11070962
GLUL Ablation Can Confer Drug Resistance to Cancer Cells via a Malate-Aspartate Shuttle-Mediated Mechanism
来源期刊:CancersDOI:10.3390/cancers11121945
Do We Really Need Another Special Issue on NF-κB in Cancer and Inflammation?
来源期刊:CancersDOI:10.3390/cancers11121978